Bei der hypersensitiven Blase handelt es sich um ein schwerwiegendes Krankheitsbild, das nach wie vor viele Rätsel aufgibt. Um die Diagnostik und Behandlung dieser seltenen Erkrankung zu verbessern, wurde nun erstmalig eine deutschsprachige S2k-Leitlinie zum Thema interstitiellen Zystitis und zum Blasenschmerzsyndrom verfasst.
Literatur
S2k-Leitlinie „Diagnostik und Therapie der Interstitiellen Cystitis (IC/BPS)“ der Deutschen Gesellschaft für Urologie (www.awmf.org/leitlinien/detail/ll/043-050.html)
Davis NF et al. Interstitial cystitis/painful bladder syndrome: epidemiology, pathophysiology and evidence-based treatment options. Eur J Obstet Gynecol Reprod Biol. 2014; 174: 30–7
Oemler M et al. Psychosocial aspects of interstitial cystitis. Do biographical factors have a relevant impact on the disease course? Der Urologe, 2006; 45: 728–33
FitzGerald M et al. Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. J Urol. 2012; 187: 2113–8
Berner MM et al. The german version of the female sexual function index (FSFI-d). Int J Impot Res. 2002; 14: 79–90
Kuo YC et al. Potential factors that can be used to differentiate between interstitial cystitis/painful bladder syndrome and bladder oversensitivity in women. Int J Clin Pract. 2012; 66: 146–51
Störkel S. Interstitielle Zystitis aus der Sicht der Pathologen. In: Interstitielle Zystitis — The State of the Art, Biermann Verlag, Köln, 2002: 43–8
Homma Y et al. Increased mRNA expression of genes involved in pronociceptive inflammatory reactions in bladder tissue of interstitial cystitis. J Urol. 2013; 190: 1925–31
Kutlar A et al. A potent oral P-selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell disease. Am J Hematol. 2012; 87: 536–9
Hanno PM et al. Conservative therapy of interstitial cystitis. Semin Urol. 1991; 9: 143–7
Jocham D et al. The care situation of patients with interstitial cystitis in Germany: results of a survey of 270 patients. Urologe A. 2013; 52: 691–702
Bouchelouche K et al. Treatment of interstitial cystitis with montelukast, a leukotriene D(4) receptor antagonist. Urology. 2001; 57 (6 Suppl 1): 118
Fleischmann J. Calcium channel antagonists in the treatment of interstitial cystitis. Urol Clin North Am. 1994; 21: 107–11
Homma Y et al. Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome. Int J Urol. 2009; 16: 597–615
Hanno PM et al. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015; 193: 1545–53
Riedl CR et al. Electromotive drug administration and hydrodistention for the treatment of interstitial cystitis. J Endourol. 1998; 12: 269–72
Peters KM et al. A prospective, single-blind, randomized crossover trial of sacral vs pudendal nerve stimulation for interstitial cystitis. BJU Int. 2007; 100: 835–9
Lampel, A., Operations Optionen bei refraktärer interstitieller Zystitis. 2014, Schwarzwald-Baar Klinikum Villingen-Schwenningen.
Irwin PP et al. Surgical management of interstitial cystitis. Urol Clin North Am. 1994; 21: 145–51
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bschleipfer, T. Erste deutsche S2k-Leitlinie zur interstitiellen Zystitis. Uro-News 23, 30–33 (2019). https://doi.org/10.1007/s00092-019-2149-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00092-019-2149-6